Zudem müssen jene Pharmaunternehmen, die von hohen Subventionen zur Einwicklung von Impfstoffen gegen COVID-19 profitiert haben, ihre Technologie mit anderen Herstellern teilen, um das Angebot zu erhöhen, so wie es das „Council on the Economics of Health for All“ der Weltgesundheitsorganisation (WHO) empfohlen hat.
In addition, the pharmaceutical firms that benefited from large COVID-19 vaccine-development subsidies must share their technology with other producers to increase supply, as the World Health Organization Council on the Economics of Health for All has recommended.